Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 2.200
0.00 (0.00%)
At close: Feb 6, 2026
Sharp Therapeutics Market Cap
Sharp Therapeutics has a market cap or net worth of CAD 66.17 million as of February 10, 2026.
Market Cap
66.17M
Enterprise Value
65.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since January 17, 2025, Sharp Therapeutics's market cap has increased from 62.09M to 66.17M, an increase of 6.57%. That is a compound annual growth rate of 6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 66.17M | -11.82% |
| Dec 30, 2025 | 75.03M | 20.85% |
| Jan 17, 2025 | 62.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 139.77M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 68.40M |
| NurExone Biologic | 61.66M |
| Sernova Biotherapeutics | 52.56M |
| MedMira | 45.33M |
| BriaCell Therapeutics | 35.41M |
| Defence Therapeutics | 35.00M |